{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:51:57Z","timestamp":1783727517052,"version":"3.55.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jash.2015.08.009","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T01:01:45Z","timestamp":1440118905000},"page":"885-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Vitamin D deficiency and essential hypertension"],"prefix":"10.1016","volume":"9","author":[{"given":"Songcang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra K.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2015.08.009_bib1","doi-asserted-by":"crossref","first-page":"e003423","DOI":"10.1136\/bmjopen-2013-003423","article-title":"Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study","volume":"3","author":"Joffres","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jash.2015.08.009_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/HJH.0b013e32834ee23c","article-title":"Essential hypertension: perspectives and future directions","volume":"30","author":"Chen","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1152\/advan.00063.2013","article-title":"The immune system in hypertension","volume":"38","author":"Trott","year":"2014","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.jash.2015.08.009_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","article-title":"Molecular mechanisms of human hypertension","volume":"104","author":"Lifton","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jash.2015.08.009_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm.2079","article-title":"The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure","volume":"16","author":"Guilluy","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jash.2015.08.009_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm1666","article-title":"G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension","volume":"14","author":"Wirth","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jash.2015.08.009_bib7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008","volume":"124","author":"Egan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2015.08.009_bib8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm.2541","article-title":"Under pressure: the search for the essential mechanisms of hypertension","volume":"17","author":"Coffman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jash.2015.08.009_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/eurheartj\/ehs455","article-title":"Genes for blood pressure: an opportunity to understand hypertension","volume":"34","author":"Ehret","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jash.2015.08.009_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4330\/wjc.v6.i5.327","article-title":"Elevated blood pressure: our family's fault? The genetics of essential hypertension","volume":"6","author":"Natekar","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jash.2015.08.009_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trsl.2014.06.007","article-title":"Epigenetics and arterial hypertension: the challenge of emerging evidence","volume":"165","author":"Friso","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.jash.2015.08.009_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.semnephrol.2013.05.011","article-title":"Epigenomics of hypertension","volume":"33","author":"Liang","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jash.2015.08.009_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/jhh.2014.99","article-title":"The emerging role of non-coding RNA in essential hypertension and blood pressure regulation","volume":"29","author":"Marques","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.annepidem.2007.12.001","article-title":"Vitamin D status: measurement, interpretation, and clinical application","volume":"19","author":"Holick","year":"2009","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jash.2015.08.009_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2015.08.009_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2015.08.009_bib17","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2015.08.009_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.200803024","article-title":"FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis","volume":"182","author":"Medici","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jash.2015.08.009_bib19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.108.119602","article-title":"Expression of the vitamin d receptor is increased in the hypertrophic heart","volume":"52","author":"Chen","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib20","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","article-title":"25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds","volume":"111","author":"Somjen","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2015.08.009_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1681\/ASN.V133621","article-title":"Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion","volume":"13","author":"Zehnder","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2015.08.009_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1741-7015-11-163","article-title":"Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease","volume":"11","author":"Handel","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jash.2015.08.009_bib23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI114097","article-title":"Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries","volume":"83","author":"Merke","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2015.08.009_bib24","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1172\/JCI115213","article-title":"1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells","volume":"87","author":"Mitsuhashi","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2015.08.009_bib25","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.1074\/jbc.274.16.11260","article-title":"Vitamin D-dependent suppression of human atrial natriuretic peptide gene promoter activity requires heterodimer assembly","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jash.2015.08.009_bib26","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.HYP.31.6.1338","article-title":"Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains","volume":"31","author":"Chen","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib27","doi-asserted-by":"crossref","first-page":"15039","DOI":"10.1074\/jbc.275.20.15039","article-title":"Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter","volume":"275","author":"Chen","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jash.2015.08.009_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jsbmb.2012.08.006","article-title":"Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1alpha,25-dihydroxyvitamin D3-responsive genes","volume":"136","author":"Meyer","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jash.2015.08.009_bib29","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","article-title":"Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2015.08.009_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2015.08.009_bib31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-155-12-201112200-00004","article-title":"New insights about vitamin D and cardiovascular disease: a narrative review","volume":"155","author":"McGreevy","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2015.08.009_bib32","first-page":"4641","article-title":"Vitamin D and cardiovascular disease","volume":"34","author":"Zittermann","year":"2014","journal-title":"Anticancer Research"},{"key":"10.1016\/j.jash.2015.08.009_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11906-014-0464-6","article-title":"Vitamin D deficiency in the pathogenesis of hypertension: still an unsettled question","volume":"16","author":"Rostand","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jash.2015.08.009_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MNH.0b013e32835d919b","article-title":"Does vitamin D modulate blood pressure?","volume":"22","author":"Tamez","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2215\/CJN.02960410","article-title":"Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis","volume":"5","author":"Rostand","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2015.08.009_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.HYP.30.2.150","article-title":"Ultraviolet light may contribute to geographic and racial blood pressure differences","volume":"30","author":"Rostand","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(05)60827-6","article-title":"Ultraviolet B and blood pressure","volume":"352","author":"Krause","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2015.08.009_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1751-7176.2010.00408.x","article-title":"25-hydroxyvitamin D levels and hypertension rates","volume":"13","author":"Bhandari","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2015.08.009_bib39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0007114511005745","article-title":"Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies","volume":"108","author":"Dorjgochoo","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","article-title":"Prevalence and correlates of vitamin D deficiency in US adults","volume":"31","author":"Forrest","year":"2011","journal-title":"Nutr Res"},{"key":"10.1016\/j.jash.2015.08.009_bib41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejcn.1602825","article-title":"Vitamin D status and health correlates among German adults","volume":"62","author":"Hintzpeter","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib42","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2015.08.009_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000330716","article-title":"Serum vitamin D level and prehypertension among subjects free of hypertension","volume":"35","author":"Sabanayagam","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jash.2015.08.009_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjhyper.2007.01.017","article-title":"Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey","volume":"20","author":"Scragg","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000341277","article-title":"Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population","volume":"123","author":"Skaaby","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.jash.2015.08.009_bib46","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","article-title":"Plasma 25-hydroxyvitamin D levels and risk of incident hypertension","volume":"49","author":"Forman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib47","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/HYPERTENSIONAHA.108.117630","article-title":"Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women","volume":"52","author":"Forman","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib48","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/ajh\/hpt051","article-title":"Hypertension, pulse, and other cardiovascular risk factors and vitamin D status in Finnish men","volume":"26","author":"Ke","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ajh.2010.226","article-title":"Vitamin D and subsequent systolic hypertension among women","volume":"24","author":"Griffin","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/HYPERTENSIONAHA.109.143990","article-title":"Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension","volume":"55","author":"Jorde","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib51","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00394-012-0480-8","article-title":"A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men","volume":"52","author":"Wang","year":"2013","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib52","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","article-title":"Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population","volume":"106","author":"Anderson","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2015.08.009_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/aje\/kwr274","article-title":"A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women","volume":"175","author":"Margolis","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jash.2015.08.009_bib54","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/HJH.0b013e32834320f9","article-title":"Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis","volume":"29","author":"Burgaz","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10654-013-9790-2","article-title":"Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants","volume":"28","author":"Kunutsor","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jash.2015.08.009_bib56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study","volume":"2","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jash.2015.08.009_bib57","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S2213-8587(14)70119-6","article-title":"Low vitamin D and hypertension: a causal association?","volume":"2","author":"Afzal","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jash.2015.08.009_bib58","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/SMJ.0b013e3181e6d389","article-title":"Effects of vitamin D supplementation on blood pressure","volume":"103","author":"Wu","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.jash.2015.08.009_bib59","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1097\/HJH.0b013e32832f075b","article-title":"Effect of vitamin D on blood pressure: a systematic review and meta-analysis","volume":"27","author":"Witham","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-152-5-201003020-00009","article-title":"Systematic review: vitamin D and cardiometabolic outcomes","volume":"152","author":"Pittas","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2015.08.009_bib61","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2011-0398","article-title":"Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis","volume":"96","author":"Elamin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2015.08.009_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10654-013-9874-z","article-title":"Vitamin D and high blood pressure: causal association or epiphenomenon?","volume":"29","author":"Kunutsor","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jash.2015.08.009_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2014.04.011","article-title":"Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: a randomized placebo-controlled trial","volume":"235","author":"Chen","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jash.2015.08.009_bib64","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/HYPERTENSIONAHA.111.00659","article-title":"Effect of vitamin D supplementation on blood pressure in blacks","volume":"61","author":"Forman","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib65","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajh.2012.111","article-title":"Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial","volume":"25","author":"Larsen","year":"2012","journal-title":"Am J\u00a0Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MBP.0000000000000091","article-title":"The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Mozaffari-Khosravi","year":"2015","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.jash.2015.08.009_bib67","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","article-title":"Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels","volume":"25","author":"Sugden","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.jash.2015.08.009_bib68","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00125-010-1838-1","article-title":"The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial","volume":"53","author":"Witham","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jash.2015.08.009_bib69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.114.011732","article-title":"Vitamin D therapy in individuals with pre-hypertension or hypertension: the DAYLIGHT trial","volume":"131","author":"Arora","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2015.08.009_bib70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/HYPERTENSIONAHA.114.03466","article-title":"Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial","volume":"64","author":"Scragg","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib71","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.0954-6820.1988.tb15789.x","article-title":"Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance","volume":"223","author":"Lind","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jash.2015.08.009_bib72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.0954-6820.1987.tb10959.x","article-title":"Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study","volume":"222","author":"Lind","year":"1987","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jash.2015.08.009_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ajh\/2.1.20","article-title":"Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study","volume":"2","author":"Lind","year":"1989","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajh\/1.4.397","article-title":"Hypertension in primary hyperparathyroidism\u2013reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study","volume":"1","author":"Lind","year":"1988","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib75","doi-asserted-by":"crossref","first-page":"E622","DOI":"10.1210\/jc.2011-2448","article-title":"Short-term effects on bone turnover markers of a single high dose of oral vitamin D(3)","volume":"97","author":"Rossini","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2015.08.009_bib76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","article-title":"Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data","volume":"175","author":"Beveridge","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jash.2015.08.009_bib77","first-page":"1633","article-title":"Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women","volume":"86","author":"Pfeifer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2015.08.009_bib78","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.clnu.2013.01.020","article-title":"Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients","volume":"32","author":"Breslavsky","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib79","first-page":"640","article-title":"Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults","volume":"49","author":"Scragg","year":"1995","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib80","first-page":"195","article-title":"The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial","volume":"3","author":"Witham","year":"2010","journal-title":"Circ\u00a0Heart\u00a0Fail"},{"key":"10.1016\/j.jash.2015.08.009_bib81","first-page":"1672","article-title":"Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial","volume":"173","author":"Witham","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jash.2015.08.009_bib82","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/HYPERTENSIONAHA.113.02177","article-title":"Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial","volume":"63","author":"Witham","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib83","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3945\/jn.111.154005","article-title":"Incremental cholecalciferol supplementation up to 15 mug\/d throughout winter at 51-55 degrees N has no effect on biomarkers of cardiovascular risk in healthy young and older adults","volume":"142","author":"Muldowney","year":"2012","journal-title":"J Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib84","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2015.08.009_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2012.12.013","article-title":"Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes","volume":"227","author":"Yiu","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jash.2015.08.009_bib86","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/jbmr.431","article-title":"The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR)","volume":"26","author":"Tiosano","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jash.2015.08.009_bib87","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2796.2009.02181.x","article-title":"No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year","volume":"267","author":"Jorde","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.jash.2015.08.009_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1464-5491.2008.02636.x","article-title":"A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men","volume":"26","author":"Nagpal","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.jash.2015.08.009_bib89","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1017\/S0007114512000098","article-title":"Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial","volume":"108","author":"Salehpour","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00394-009-0020-3","article-title":"Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels","volume":"48","author":"Jorde","year":"2009","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib91","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","article-title":"Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial","volume":"83","author":"Schleithoff","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib92","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/HJH.0b013e328349666d","article-title":"No effect of ultraviolet radiation on blood pressure and other cardiovascular risk factors","volume":"29","author":"Scragg","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib93","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1210\/jc.2012-2126","article-title":"Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT","volume":"97","author":"Wood","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2015.08.009_bib94","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3945\/ajcn.2008.27004","article-title":"Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers","volume":"89","author":"Zittermann","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jash.2015.08.009_bib96","article-title":"Update on the Vitamin D and OmegA-3 trial (VITAL)","author":"Pradhan","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jash.2015.08.009_bib97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/HJH.0b013e328340aa30","article-title":"1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix","volume":"29","author":"Zebger-Gong","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib98","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1359\/JBMR.051211","article-title":"Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function","volume":"21","author":"Bas","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jash.2015.08.009_bib99","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000159247","article-title":"Aortic calcification produced by vitamin D3 plus nicotine","volume":"34","author":"Niederhoffer","year":"1997","journal-title":"J Vasc Res"},{"key":"10.1016\/j.jash.2015.08.009_bib100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000326903","article-title":"Vitamin D and vascular calcification in chronic kidney disease","volume":"34","author":"Rodriguez","year":"2011","journal-title":"Kidney\u00a0Blood Press Res"},{"key":"10.1016\/j.jash.2015.08.009_bib101","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.115.05319","article-title":"Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial","volume":"65","author":"Pilz","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib102","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.clnu.2014.09.015","article-title":"Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome","volume":"34","author":"Asemi","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib103","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clnu.2014.10.002","article-title":"The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: a randomized controlled trial","volume":"34","author":"Munoz-Aguirre","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jash.2015.08.009_bib104","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/GME.0000000000000188","article-title":"Calcium\/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium\/vitamin D randomized trial","volume":"21","author":"Schnatz","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.jash.2015.08.009_bib105","first-page":"42","article-title":"Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials","volume":"11","author":"Wang","year":"2012","journal-title":"Lipids\u00a0Health Dis"},{"key":"10.1016\/j.jash.2015.08.009_bib106","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","article-title":"Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2015.08.009_bib107","first-page":"E134","article-title":"Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties","volume":"258","author":"Weishaar","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jash.2015.08.009_bib108","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.109.138800","article-title":"Increased renin production in mice with deletion of peroxisome proliferator-activated receptor-gamma in juxtaglomerular cells","volume":"55","author":"Desch","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib109","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/ki.2008.452","article-title":"Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium","volume":"74","author":"Kong","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2015.08.009_bib110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.34.4.897","article-title":"Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine","volume":"34","author":"Borges","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib111","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.bjp.0702581","article-title":"Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol","volume":"127","author":"Borges","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jash.2015.08.009_bib112","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0702177","article-title":"Impaired function of alpha-2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive rats","volume":"125","author":"Feres","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jash.2015.08.009_bib113","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2353\/ajpath.2010.091292","article-title":"Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats","volume":"177","author":"Kong","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jash.2015.08.009_bib114","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.0000174602.59935.d5","article-title":"Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats","volume":"46","author":"Bolterman","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib115","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.HYP.25.5.928","article-title":"Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats","volume":"25","author":"Campbell","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib116","doi-asserted-by":"crossref","first-page":"R694","DOI":"10.1152\/ajpregu.00219.2005","article-title":"Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats","volume":"290","author":"Paliege","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jash.2015.08.009_bib117","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00004872-199607000-00010","article-title":"Altered age-dependent modulation of tissue renin messenger RNA levels in the spontaneously hypertensive rat","volume":"14","author":"Yu","year":"1996","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsbmb.2012.09.007","article-title":"Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart","volume":"136","author":"Chen","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jash.2015.08.009_bib119","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11914-008-0014-8","article-title":"Parathyroid hormone and the cardiovascular system","volume":"6","author":"Fitzpatrick","year":"2008","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jash.2015.08.009_bib120","first-page":"360","article-title":"Chronic continuous PTH infusion results in hypertension in normal subjects","volume":"2","author":"Hulter","year":"1986","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jash.2015.08.009_bib121","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1579\/0044-7447-31.7.558","article-title":"Environmental effects on the distribution of corallimorpharians in Tanzania","volume":"31","author":"Muhando","year":"2002","journal-title":"Ambio"},{"key":"10.1016\/j.jash.2015.08.009_bib122","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jash.2015.08.009_bib123","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1097\/00004872-199312050-00131","article-title":"Relationship between vitamin D and the regional blood flow and vascular resistance in moderate arterial hypertension","volume":"11","author":"Duprez","year":"1993","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.jash.2015.08.009_bib124","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/HYPERTENSIONAHA.114.03971","article-title":"Elimination of vitamin D receptor in vascular endothelial cells alters vascular function","volume":"64","author":"Ni","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2015.08.009_bib125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jsbmb.2009.11.002","article-title":"Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity","volume":"118","author":"Chen","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jash.2015.08.009_bib126","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jsbmb.2010.08.007","article-title":"A role for the cell cycle phosphatase Cdc25a in vitamin D-dependent inhibition of adult rat vascular smooth muscle cell proliferation","volume":"122","author":"Chen","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jash.2015.08.009_bib127","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1681\/ASN.2004090797","article-title":"1,25 dihydroxyvitamin d amplifies type a natriuretic peptide receptor expression and activity in target cells","volume":"16","author":"Chen","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jash.2015.08.009_bib128","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1113\/jphysiol.2011.214726","article-title":"Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats","volume":"589","author":"Tare","year":"2011","journal-title":"J Physiol"},{"key":"10.1016\/j.jash.2015.08.009_bib129","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jash.2015.08.009_bib130","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.0801543","article-title":"Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response","volume":"182","author":"Tang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jash.2015.08.009_bib131","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1101\/gr.107920.110","article-title":"A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution","volume":"20","author":"Ramagopalan","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.jash.2015.08.009_bib132","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.108.846634","article-title":"Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension","volume":"119","author":"Brahler","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2015.08.009_bib133","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.RES.0000238377.08219.0c","article-title":"Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel","volume":"99","author":"Si","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jash.2015.08.009_bib134","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/378065a0","article-title":"Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide","volume":"378","author":"Lopez","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jash.2015.08.009_bib135","doi-asserted-by":"crossref","first-page":"14730","DOI":"10.1073\/pnas.94.26.14730","article-title":"Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A","volume":"94","author":"Oliver","year":"1997","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171115006269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171115006269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T18:56:25Z","timestamp":1653072985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171115006269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":135,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1933171115006269"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2015.08.009","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D deficiency and essential hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2015.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}